Metabolic Regulation

Metabolic regulation is the set of chemical mechanisms that adjust the rates of pathways so that supply matches demand and opposing pathways do not run wastefully at the same time.

Definition

Metabolic regulation is the coordinated control of metabolic flux achieved by modulating enzyme activity and abundance, especially at the rate-limiting, committed steps of pathways.

Scope

This topic covers control of enzyme activity through allosteric regulation, covalent modification such as phosphorylation, feedback inhibition, control of enzyme amount, and the logic of regulating committed, irreversible steps; it includes the major allosteric models that explain cooperative, sigmoidal kinetics.

Core questions

• Why are committed, irreversible steps the usual points of control?
• How do allosteric effectors change enzyme activity without binding the active site?
• What distinguishes the concerted and sequential models of allostery?
• How does covalent modification provide rapid, reversible control?

Key theories

Concerted (MWC) model of allostery

Monod, Wyman, and Changeux proposed that allosteric proteins exist in equilibrium between two symmetric conformational states, with ligands shifting the equilibrium, accounting for cooperative binding curves.

Sequential (KNF) model of allostery

Koshland, Némethy, and Filmer proposed that ligand binding induces conformational change in one subunit that progressively alters neighboring subunits, providing an induced-fit-based account of cooperativity.

Mechanisms

Regulatory enzymes typically catalyze the committed step of a pathway and respond to signals that report on cellular state. Allosteric effectors bind sites distinct from the active site, shifting the enzyme between conformations of higher and lower activity and producing sigmoidal kinetics; feedback inhibition by a pathway's end product is a common example. Covalent modification, especially reversible phosphorylation, and changes in enzyme synthesis and degradation provide additional, slower layers of control.

Clinical relevance

The principles of allosteric and covalent control are central to enzymology and the rational understanding of how chemical networks are governed; they inform biocatalyst engineering. The treatment is descriptive and non-prescriptive.

History

The concept of allosteric feedback inhibition emerged around 1960; the concerted MWC model (1965) and the sequential KNF model (1966) provided competing quantitative frameworks, while the discovery of reversible phosphorylation by Fischer and Krebs established covalent modification as a major regulatory mechanism.

Debates

Concerted versus sequential models of allostery

The MWC concerted model assumes all subunits switch state together preserving symmetry, while the KNF sequential model allows subunit-by-subunit change; real proteins show features of both, and the two are often treated as limiting cases of a general framework.

Key figures

• Jacques Monod
• Jean-Pierre Changeux
• Daniel Koshland
• Edmond Fischer
• Edwin Krebs

Seminal works

• monod1965
• koshland1966
• nelson2021

Frequently asked questions

What is feedback inhibition?

Feedback inhibition is a regulatory mechanism in which the end product of a pathway inhibits an enzyme early in that pathway, automatically slowing production when the product accumulates.

What makes an enzyme allosteric?

An allosteric enzyme has a regulatory site separate from its active site; binding of an effector there changes the enzyme's conformation and activity, often producing cooperative, sigmoidal kinetics.